cyclooct-4-yn-1-ol | 67959-50-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: cyclooct-4-yn-1-ol
• 英文别名: 4-Cyclooctin-1-ol；5-Hydroxycyclooctin；4-Cyclooctyn-1-ol
• CAS: 67959-50-6
• 化学式: C₈H₁₂O
• 分子量: 124.183
• InChiKey: BJAZRFGMPTUAMV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  cyclooct-4-yn-1-ol 在 吡啶 、 乙醇 、 三乙胺 作用下， 反应 528.0h， 生成 (Z)-cyclooct-4-enol
  参考文献：
  名称：

  Hanack, Michael; Spang, Werner, Chemische Berichte, 1980, vol. 113, # 5, p. 2015 - 2024

  摘要：

  DOI：
• 作为产物：
  描述：

  5-羟基环辛酮 在 正丁基锂 、 selenium(IV) oxide 、 碘甲烷 作用下， 以 1,4-二氧六环 、 乙醇 、 水 为溶剂， 反应 3.5h， 生成 cyclooct-4-yn-1-ol
  参考文献：
  名称：

  Hanack, Michael; Spang, Werner, Chemische Berichte, 1980, vol. 113, # 5, p. 2015 - 2024

  摘要：

  DOI：

文献信息

• [EN] BIOMOLECULE CONJUGATES<br/>[FR] CONJUGUÉS DE BIOMOLÉCULE
  申请人：CELGENE CORP

  公开号：WO2016090157A1

  公开（公告）日：2016-06-09

  The present invention relates to biomolecule conjugates which comprise a biomolecule wherein at least one non-natural amino acid (NNAA) is integral to the structure of the biomolecule and wherein the NNAA is a point of attachment of a linker to which a payload, particularly a cytotoxic agent, is attached. More specifically, this invention relates to conjugates of cell-binding agents and active release products comprising cytotoxic agents wherein the conjugates are produced by means of a cycloaddition reaction. Methods of production, pharmaceutical compositions and methods of use are provided.

  本发明涉及生物分子共轭物，其包括一种生物分子，其中至少有一种非天然氨基酸（NNAA）构成生物分子的结构，并且NNAA是连接物的附着点，连接物上附着有一种荷载物，特别是细胞毒性药剂。更具体地说，本发明涉及细胞结合剂和活性释放产物的共轭物，其中共轭物是通过环加成反应制备的。提供了生产方法、药物组合物和使用方法。
• [EN] MODIFIED ANTIBODY, ANTIBODY-CONJUGATE AND PROCESS FOR THE PREPARATION THEREOF<br/>[FR] ANTICORPS MODIFIÉ, ANTICORPS-CONJUGUÉ ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ
  申请人：SYNAFFIX BV

  公开号：WO2014065661A1

  公开（公告）日：2014-05-01

  The present invention relates to an antibody comprising a GlcNAc-S(A)x substituent, wherein S(A)x is a sugar derivative comprising x functional groups A wherein A is independently selected from the group consisting of an azido group, a keto group and an alkynyl group and x is 1, 2, 3 or 4, wherein said GlcNAc-S(A)x substituent is bonded to the antibody via CI of the N-acetylglucosamine of said GlcNAc-S(A)x substituent, and wherein said N-acetylglucosamine is optionally fucosylated. The invention also relates to an antibody-conjugate, in particular to an antibody- conjugate according to the Formula (20) or (20b), wherein AB is an antibody, S is a sugar or a sugar derivative, D is a molecule of interest, and wherein said N- acetylglucosamine is optionally fucosylated (b is 0 or 1). The invention further relates to a process for the preparation of a modified antibody, to a process for the preparation of an antibody-conjugate, and to said antibody-conjugate for use as a medicament. In addition, the invention relates to a kit of parts comprising an azide-modified antibody and a linker-conjugate, wherein said linker-conjugate comprises a (hetero)cycloalkynyl group and one or more molecules of interest.

  本发明涉及一种包含GlcNAc-S(A)x取代基的抗体，其中S(A)x是一种包含x个功能基团A的糖衍生物，其中A是从包括偶氮基、酮基和炔基的组中独立选择的，x为1、2、3或4，其中所述的GlcNAc-S(A)x取代基通过所述的GlcNAc-S(A)x取代基的N-乙酰葡萄糖胺的CI与抗体结合，其中所述的N-乙酰葡萄糖胺可选择地被岩藻糖化。本发明还涉及一种抗体结合物，特别是根据式（20）或（20b）的抗体结合物，其中AB是一种抗体，S是一种糖或糖衍生物，D是一种感兴趣的分子，其中所述的N-乙酰葡萄糖胺可选择地被岩藻糖化（b为0或1）。本发明还涉及一种改性抗体的制备方法，一种抗体结合物的制备方法，以及用作药物的所述抗体结合物。此外，本发明还涉及一种部件套件，包括偶氮基修饰的抗体和连接物结合物，其中所述的连接物结合物包括（杂）环炔基团和一个或多个感兴趣的分子。
• PROCESS FOR THE CYCLOADDITION OF A HETERO(ARYL) 1,3-DIPOLE COMPOUND WITH A (HETERO)CYCLOALKYNE
  申请人：SYNAFFIX B.V.

  公开号：US20170002012A1

  公开（公告）日：2017-01-05

  A process is provided, comprising reacting a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne, wherein the (hetero)aryl 1,3-dipole compound comprises a 1,3-dipole functional group bonded to a (hetero)aryl group, and wherein the (hetero)aryl 1,3-dipole compound is a (hetero)aryl azide or a (hetero)aryl diazo compound; wherein: (i) the (hetero)aryl group of the (hetero)aryl 1,3-dipole compound comprises a substituent (ii) the (hetero)aryl group of the (hetero)aryl 1,3-dipole compound is an electron-poor (hetero)aryl group and wherein the (hetero)cycloalkyne is a (hetero)cyclooctyne or a (hetero)cyclononyne according to Formula (1). The invention also relates to the products obtainable by the process according to the invention.

  提供一种方法，包括将（杂）芳基1,3-二极化合物与（杂）环炔反应，其中（杂）芳基1,3-二极化合物包括与（杂）芳基结合的1,3-二级极功能基团，并且（杂）芳基1,3-二极化合物是（杂）芳基叠氮化物或（杂）芳基重氮化合物；其中：（i）（杂）芳基1,3-二极化合物的（杂）芳基包括一个取代基（ii）（杂）芳基1,3-二极化合物的（杂）芳基是一个电子贫富（杂）芳基，并且（杂）环炔是根据式（1）的（杂）环辛烯或（杂）环壬炔。该发明还涉及根据该发明的方法获得的产品。
• [EN] PROCESS FOR THE CYCLOADDITION OF A HETERO(ARYL) 1,3-DIPOLE COMPOUND WITH A (HETERO)CYCLOALKYNE<br/>[FR] PROCÉDÉ DE CYCLOADDITION D'UN COMPOSÉ HÉTÉRO(ARYL) 1,3-DIPOLE AVEC UN (HÉTÉRO)CYCLOALKYNE
  申请人：STICHTING KATHOLIEKE UNIV

  公开号：WO2015112014A1

  公开（公告）日：2015-07-30

  The present invention relates to a process comprising the step of reacting a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne, wherein: a (hetero)aryl 1,3-dipole compound is defined as a compound comprising a 1,3-dipole functional group, wherein the 1,3-dipole functional group is bonded to a (hetero)aryl group, and wherein the (hetero)aryl 1,3-dipole compound is a (hetero)aryl azide or a (hetero)aryl diazo compound; wherein: (i) the (hetero)aryl group of the (hetero)aryl 1,3-dipole compound comprises one or more substituents having a positive value for the para-Hammett substituent constant σp and/or the meta-Hammett substituent constant σm, and/or (ii) the (hetero)aryl group of the (hetero)aryl 1,3-dipole compound is an electron-poor (hetero)aryl group, wherein an electron-poor (hetero)aryl group is: (ii-a) a (hetero)aryl group wherein the (hetero)aromatic ring system is bearing a positive charge, and/or (ii-b) a (hetero)aryl group wherein the ratio number of π-electrons present in the (hetero)aromatic ring system} : number of protons present in the nuclei of the (hetero)aromatic ring system} is lower than 0.167 for a 6-membered ring, or lower than 0.200 for a 5-membered ring; and wherein the (hetero)cycloalkyne is a (hetero)cyclooctyne or a (hetero)cyclononyne according to Formula (1): The invention also relates to the products obtainable by the process according to the invention.

  本发明涉及一种包括以下步骤的过程：将（杂）芳基1,3-二极化合物与（杂）环戊炔发生反应，其中：（杂）芳基1,3-二极化合物被定义为包含1,3-二极功能基团的化合物，其中1,3-二极功能基团与（杂）芳基团结合，而（杂）芳基1,3-二极化合物是（杂）芳基叠氮化物或（杂）芳基重氮化合物；其中：（i）（杂）芳基1,3-二极化合物的（杂）芳基团包括一个或多个对位Hammett取代常数σp和/或间位Hammett取代常数σm的正值取代基，和/或（ii）（杂）芳基1,3-二极化合物的（杂）芳基团是一个电子贫穷的（杂）芳基团，其中电子贫穷的（杂）芳基团是：（ii-a）一个（杂）芳基团，其中（杂）芳香环系统带有正电荷，和/或（ii-b）一个（杂）芳基团，其中比例（杂）芳香环系统中存在的π电子数}：（杂）芳香环系统中核内质子数}对于6元环小于0.167，或对于5元环小于0.200；其中（杂）环戊炔是根据式（1）的（杂）环辛炔或（杂）环壬炔；该发明还涉及根据该发明的过程获得的产品。
• [EN] IMPROVED CONJUGATION LINKERS<br/>[FR] LIEURS DE CONJUGAISON AMÉLIORÉS
  申请人：PROLYNX LLC

  公开号：WO2020206358A1

  公开（公告）日：2020-10-08

  Provided are β-eliminative linkers suitable for the conjugation of small molecule, peptide, and protein and compounds comprising the linkers.

  提供了适用于小分子、肽和蛋白质共轭的β-消除连接物以及包含这些连接物的化合物。